Home » Quidel Posts 21 Percent Revenue Growth for Q4

Quidel Posts 21 Percent Revenue Growth for Q4

Mar 01, 2012

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market Wednesday that its fourth-quarter revenues increased 21 percent year over year driven by its infectious disease and women's health products.

The San Diego-based diagnostics firm generated total revenues of $38.4 million for the three-month period ended Dec. 31, 2011, compared to $31.7 million for Q4 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Feb 11, 2015

Quidel Q4 Revenues Grow 27 Percent on Infectious Disease Sales

Jul 23, 2014

Quidel Q2 Revenues Up 6 Percent

Apr 23, 2014

Quidel Q1 Revenues Drop 26 Percent

Mar 13, 2014

Transgenomic Posts 12 Percent Q4 Revenue Decline

Jun 10, 2014

Enzo Biochem Q3 Revenues Rise 6 Percent

Oct 21, 2014

Quidel Q3 Revenues Grow 22 Percent

The Scan

This Week in Science

In Science this week: gene linked to expansion of the human neocortex, and more.

Bit of an Increase

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient Wheat

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

'High School Never Ends'

Joel Achenbach explores at National Geographic why people find science difficult to believe.

What's Popular?

In PCR

  1. Germany's GNA Biosolutions Developing Ultrafast 'Laser PCR' Ebola Test, Pathogen Testing Platform

    Premium

  2. BioFire Diagnostics Receives FDA Clearance for FilmArray 2.0 System

  3. New Data Supports AR-V7 Testing to Guide Prostate Cancer Treatment

    Premium

  4. Bio-Rad Reports Q4 Revenues Down 1 Percent

  5. Abbott's Plex-ID Outperforms RT-PCR and Microarrays in FDA Viral ID Study

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.